Fri Jan 10 15:01:16 UTC 2025: ## Ozempic’s Weight-Loss Appeal Masks Serious Health Risks, Nutritionist Warns
**Mumbai, India** – The popular diabetes medication Ozempic, which gained notoriety in 2023 for its off-label use as a weight-loss drug, is facing renewed scrutiny. Nutritionist Nmami Agarwal recently issued a strong cautionary message on Instagram, highlighting the potential for serious side effects, including blindness and Non-Arteritic Ischemic Optic Neuropathy (NAIOD), a condition causing sudden vision loss.
Agarwal’s concerns center around the risks associated with Ozempic’s appetite-suppressing effects, particularly for those using it for weight loss without a proper medical diagnosis. While the drug effectively manages Type 2 diabetes by regulating blood sugar, its impact on those without the condition remains largely unstudied. Sudden blood sugar or blood pressure fluctuations, potentially triggered by Ozempic, are cited as contributing factors to vision complications.
Furthermore, Agarwal points out that any weight loss achieved with Ozempic is often temporary, with weight frequently returning once the medication is discontinued. This underscores the drug’s ineffectiveness as a long-term solution for weight management. Beyond potential vision problems, users report common side effects such as nausea and digestive issues.
The FDA approved injectable medications for diabetes treatment in 2017, and later approved a higher-dose version of Ozempic for obesity in 2021. However, Agarwal emphasizes the importance of sustainable lifestyle changes, including balanced diets and regular exercise, over relying on medication as a quick fix. She stresses the need for proper medical guidance before using Ozempic or similar medications to avoid potentially life-altering consequences.
**Disclaimer:** *This article provides generic information only and should not be considered medical advice. Consult a healthcare professional for any health concerns.*
First Piper 